The pharmaceuticals industry has come under heavy scrutiny in recent years for soaring prices, though much of the attention has focused on name-brand drugs with no or minimal competition. However, multiple news reports now claim that some generic drug companies could soon face federal criminal charges over allegations that they colluded on price. [More]
